华宝医药生物混合C
(019029.jj )
基金经理张金涛基金类型混合型成立日期2023-08-30总资产规模1.55亿 (2026-06-30) 基金净值3.0680 (2026-09-14) 管理费用率1.20%管托费用率0.20% (2026-09-01) 成立以来分红再投入年化收益率8.43% (2608 / 9450)
备注 (0): 双击编辑备注
发表讨论

华宝医药生物混合C(019029) - 基金对比

最后更新于:2026-09-14

数据选项
非全收益率指数点位的计算不包含分红再投入,所以理论上指数基金的分红再投入收益率高于其对应的指数点位涨幅。
加载中......
比较起始时间为2026-09-14,最多展示50条数据。
日期华宝医药生物混合C - 相对起始点分红再投入收益率沪深300 - 相对起始点收益率
2026-09-1444.51%41.28%
2026-09-1138.86%42.23%
2026-09-1040.98%43.44%
2026-09-0943.62%44.20%
2026-09-0846.40%43.76%
2026-09-0745.69%44.28%
2026-09-0446.63%43.43%
2026-09-0347.95%43.57%
2026-09-0245.83%43.42%
2026-09-0145.03%45.42%
2026-08-3145.97%45.86%
2026-08-2849.03%45.35%
2026-08-2750.54%46.02%
2026-08-2650.78%44.77%
2026-08-2550.59%43.55%
2026-08-2447.01%43.90%
2026-08-2153.23%45.66%
2026-08-2057.28%44.84%
2026-08-1952.61%44.71%
2026-08-1856.29%49.03%
2026-08-1755.58%49.51%
2026-08-1453.74%47.14%
2026-08-1355.20%47.08%
2026-08-1254.17%47.93%
2026-08-1155.39%47.08%
2026-08-1055.25%48.28%
2026-08-0754.22%48.04%
2026-08-0645.08%46.68%
2026-08-0545.12%46.90%
2026-08-0442.02%45.09%
2026-08-0338.01%43.27%
2026-07-3140.79%44.69%
2026-07-3039.43%43.48%
2026-07-2944.37%45.07%
2026-07-2845.93%44.10%
2026-07-2749.74%48.29%
2026-07-2448.19%46.62%
2026-07-2353.65%49.10%
2026-07-2252.94%48.76%
2026-07-2153.56%49.45%
2026-07-2052.76%45.01%
2026-07-1747.57%42.83%
2026-07-1659.16%48.17%
2026-07-1561.52%50.95%
2026-07-1455.20%51.26%
2026-07-1351.95%48.07%
2026-07-1053.32%50.77%
2026-07-0948.85%53.78%
2026-07-0845.50%49.97%
2026-07-0749.41%51.13%